BBIO vs DE · rev $221.9M vs P/E 25, rev $45.68B
BridgeBio Pharma Inc (BBIO) versus Deere & Company (DE) — a side-by-side from cached financials, not a winner call.
BridgeBio Pharma Inc (BBIO) is a biotechnology company listed on US.
Deere & Company (DE) is a farm & heavy construction machinery company listed on US. It is led by John May.
Latest reported BBIO revenue for 2024-12-31 was $221.9M. Net income was -$543.3M. Revenue was up 2285.3% from 2023-12-31 to 2024-12-31. BBIO currently screens at market cap $13.24B.
Latest reported DE revenue for 2025-11-02 was $45.68B. Net income was $5.03B. Revenue was down 11.7% from 2024-10-27 to 2025-11-02. DE currently screens at market cap $137.72B and trailing P/E 24.6.
BBIO currently screens at market cap $13.24B. DE currently screens at market cap $137.72B and trailing P/E 24.6.
Not investment advice. Open the BBIO and DE stock pages for the full models.
Not investment advice.